Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, reaffirming its passive beneficial ownership of 6.1% of Vital Farms, Inc.'s Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.9% Stake in Zeta Global Holdings Corp.
Investment giant BlackRock, Inc. has reported a 6.9% beneficial ownership stake in Zeta Global Holdings Corp. common stock as of March 31, 2025, held for ordinary course of business.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.6% beneficial ownership stake in Air Products and Chemicals Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Passive Stake in Alector Inc., Discloses 6.2% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a 6.2% beneficial ownership stake in Alector Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.3% Passive Stake in Sandisk Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.3% beneficial ownership stake in Sandisk Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reporting a 7.1% passive beneficial ownership stake in SmartFinancial Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in Travelers Companies, Inc. common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, reporting a 7.5% beneficial ownership stake in Travere Therapeutics, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 8.4% Stake in Veracyte, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its beneficial ownership of 8.4% of Veracyte, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.3% Stake in Backblaze Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.3% beneficial ownership stake in Backblaze Inc.'s Class A common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 8.0% of CTO Realty Growth, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 7.5% of General Motors Co.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Grand Canyon Education, Maintains Significant Passive Ownership
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a 9.1% beneficial ownership stake in Grand Canyon Education Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.2% Passive Stake in Ingersoll Rand Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.2% passive beneficial ownership stake in Ingersoll Rand Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.9% beneficial ownership stake in the iShares Core Total USD Bond Market ETF as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.8% beneficial ownership stake in Kura Oncology Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.2% beneficial ownership stake in LendingTree Inc. as of March 31, 2025, held for passive investment purposes.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.2% beneficial ownership stake in MasterCraft Boat Holdings Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, revealing a 6.3% beneficial ownership stake in Match Group, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.3% passive beneficial ownership stake in Nextdoor Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 12 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in Nu Skin Enterprises Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.7% Stake in OneMain Holdings, Inc. via Amended Schedule 13G Filing
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.7% beneficial ownership stake in OneMain Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.7% beneficial ownership stake in Pacific Biosciences of California, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reaffirming its passive beneficial ownership of 8.1% of PagerDuty, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.0% beneficial ownership stake in Phreesia, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, reporting a 6.6% beneficial ownership stake in PlayAGS Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.9% Passive Stake in Pure Storage, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.9% passive beneficial ownership stake in Pure Storage, Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a 7.2% beneficial ownership stake in RE/MAX Holdings, Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.2% Passive Stake in Sage Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.2% passive beneficial ownership stake in Sage Therapeutics Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.5% Passive Stake in TPG RE Finance Trust, Inc. via Latest SEC Filing
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, reporting a 6.5% beneficial ownership stake in TPG RE Finance Trust, Inc. as of March 31, 2025.